Condition
Rapidly Progressive Glomerulonephritis
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 3 (1)
Trial Status
Unknown1
Recruiting1
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05946564Phase 3Recruiting
A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial
NCT02647255Phase 2Terminated
Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy
NCT03201406Unknown
Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease
Showing all 3 trials